Oncura

Vincristine + Dactinomycin: what to expect, day by day

Wilms Tumor21-day cycle6 effects documented

A standard, generally well-tolerated combination for Wilms tumor. The main things to watch are nerve effects and constipation from vincristine (use the recommended bowel routine), and lowered blood counts and mouth sores from dactinomycin. Uncommonly, dactinomycin can affect the liver — the team monitors bloodwork.

Vincristine + dactinomycin (actinomycin-D) — a well-established, generally well-tolerated regimen for Wilms tumor (a childhood kidney cancer). Vincristine can cause nerve effects and constipation (cumulative); dactinomycin can lower blood counts, cause mouth sores, and — uncommonly — affect the liver (veno-occlusive disease). It can also 'recall' a skin reaction in a prior radiation area.

Get help straight away — this is true on any regimen, on any day.

A temperature of 100.4°F (38°C) or higher during treatment can mean a serious infection while your blood counts are low. Call your team or go to the ER — do not wait it out.

Also urgent: trouble breathing or chest pain · swelling of the face, lips or throat · new confusion or fainting · shaking chills · not being able to keep fluids down.

This is standing guidance shown to everyone. Nothing on this page is based on anything about you, and nobody is monitoring you.

Timed to the cycle

Day 1 is the day of your infusion. These are the effects a retrievable document ties to a day range for this regimen — not a prediction about you.

Mouth sores (mucositis)

Typically around days 3–14 · usually worst around days 7–14

Soreness or ulcers in the mouth, usually in the first 1-2 weeks. Gentle mouth care and a bland diet help.

Call your team: Can't eat or drink because of mouth pain.

reported by about common% of people · Timing from a clinical guideline · from Dactinomycin

Not tied to a cycle day

These build with the number of doses, or are measured from when treatment started, so a cycle day would be the wrong shape for them. Each keeps the timing its own source states.

Nerve effects and constipation (vincristine)

builds over doses; often improves after treatment

Vincristine can cause numbness, tingling, or weakness (including foot drop or jaw pain) and commonly slows the bowel, causing constipation — occasionally a more serious blockage. Use the recommended bowel routine from the start and report constipation, belly pain, or new weakness.

Call your team: No bowel movement for 3 days with belly pain, or new weakness/trouble walking.

reported by about common with cumulative dosing% of people · from Vincristine

Low blood counts

Dactinomycin can lower infection-fighting white cells, platelets, and red cells; counts are checked before each dose. Watch for fever, bruising, or bleeding.

Call your team urgently: A temperature of 100.4°F (38.0°C) or higher — an emergency.

reported by about common% of people · from Dactinomycin

Nausea

Sickness in the first 24 hours is the "acute" phase and usually peaks 2-3 hours in; anything from 24 to 120 hours is the "delayed" phase.

Usually mild-moderate and controlled with anti-nausea medicine.

reported by about common% of people · Timing from a clinical guideline · from Dactinomycin

Liver effect (veno-occlusive disease, uncommon)

within weeks of a dose

Uncommonly, dactinomycin can cause a liver problem (veno-occlusive disease) — signs include belly swelling, tenderness over the liver, weight gain, and yellowing. It's more likely in young children. The team monitors liver tests; report these symptoms.

Call your team urgently: Belly swelling with pain, rapid weight gain, or yellowing of skin/eyes.

reported by about uncommon% of people · from Dactinomycin

Hair loss / radiation recall

Hair loss is common and regrows after treatment. Dactinomycin can also 'recall' a skin reaction (redness/soreness) in an area that was previously irradiated.

reported by about hair loss common% of people · from Dactinomycin, Vincristine

Where this comes from

  1. S1. Vincristine sulfate FDA prescribing information — FDA label
  2. S2. Dactinomycin (Cosmegen) FDA prescribing information (myelosuppression; hepatic VOD; radiation recall) — FDA label
  3. S3. Children's Oncology Group Wilms tumor regimen EE4A — protocol

Timing windows on this page rest on:

A window appears here only where a retrievable document ties it to a drug in this regimen. Where nothing could be found, the window was removed rather than estimated — so a missing time is an honest gap, not an oversight.

Track your own cycle in Oncura →

Free, no account, nothing leaves your device.